rhenium-186 hedp has been researched along with Kahler Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dohmen, BM; Einsele, H; Kanz, L; Wiesmann, A | 1 |
1 other study(ies) available for rhenium-186 hedp and Kahler Disease
| Article | Year |
|---|---|
Complete remission after myeloablation with bone-seeking 186Re-HEDP and high-dose melphalan followed by autologous stem cell transplantation in a patient with chemorefractory multiple myeloma.
Topics: Bone and Bones; Disease-Free Survival; Etidronic Acid; Humans; Melphalan; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Organometallic Compounds; Peripheral Blood Stem Cell Transplantation; Radioisotopes; Remission Induction; Rhenium; Salvage Therapy; Transplantation, Autologous | 2005 |